Balance Sheet for Sorrento Therapeutics Inc. (SRNE)

$ 4.923   -0.247 (-4.78%) Volume: 7.93m 10:27 AM EDT May 28, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 22,521 158,738 20,429 82,398 39,038
Restrictable Cash 13,098 9,592 - - -
Marketable Securities 801 297 441 1,106 97,366
Accounts Receivable 14,454 3,833 2,211 1,696 903
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 14,513 4,359 3,926 2,985 2,618
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 3,362 2,898 - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 3,362 2,898 - - -
Prepaid Expenses 14,094 3,977 4,904 3,165 1,996
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 67,588 179,564 29,700 89,654 141,018
Land and Improvements - - - - -
Buildings and Improvement 13,161 9,001 7,327 3,625 2,034
Machinery, Furniture and Equipment 35,207 29,449 21,396 14,004 7,929
Construction in Progress 3,855 1,221 - - -
Fixed Assets, Other 46,384 - - - -
Fixed Assets, Total 98,607 39,671 28,723 17,629 9,963
Gross Fixed Assets 98,607 39,671 28,723 17,629 9,963
Accumulated Depreciation (22,335) (15,287) (9,378) (4,922) (2,717)
Net Fixed Assets 76,272 24,384 19,345 12,707 7,246
Intangibles 63,308 66,283 71,013 64,766 3,912
Cost in Excess 38,298 38,298 38,298 41,548 20,626
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 49,925 50,570 3,250 3,909 590
Total Non-Current Assets 490,044 444,523 401,913 311,932 202,501
Total Assets 557,632 624,087 431,613 401,586 343,519
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 28,538 25,129 63,120 56,644 13,339
Short Term Debt 39,583 10,150 2,407 209 4,835
Notes Payable - - - - -
Accrued Expenses 34,642 23,639 11,759 8,306 6,288
Accrued Liabilities 34,642 23,639 11,759 8,306 6,288
Deferred Revenues 3,643 2,703 3,864 9,666 -
Current Deferred Income Taxes (373) (6,119) (35,679) 982 33,337
Other Current Liabilities 8,800 - (2,195) 1,260 6,411
Total Current Liabilities 115,206 61,621 78,955 76,085 30,873
Long Term Debt 199,088 223,136 5,211 47,107 4,394
Deferred Income Tax 9,043 9,416 15,535 53,238 49,341
Other Non-Current Liabilities 149,428 122,414 125,302 138,654 117,973
Minority Interest (45,832) (1,972) 7,042 6,465 (4,214)
Capital Lease Obligations 52,111 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 363,838 352,994 153,090 245,464 167,494
Total Liabilities 479,044 414,615 232,045 321,549 198,367
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 78,588 209,472 199,568 80,037 145,152
Common Par 18 13 9 6 4
Additional Paid in Capital 788,122 626,658 413,901 303,865 184,898
Cumulative Translation Adjustments - - - - -
Retained Earnings (659,818) (367,750) (165,120) (174,252) (113,329)
Treasury Stock 49,464 49,464 49,464 49,464 -
Other Equity Adjustments (270) 15 242 (118) 73,579
Total Capitalization 277,676 432,608 204,779 127,144 149,546
Total Equity 78,588 209,472 199,568 80,037 145,152
Total Liabilities & Shareholder's Equity 557,632 624,087 431,613 401,586 343,519
Cash Flow (363,012) (212,528) 11,110 (63,938) (50,074)
Working Capital (47,618) 117,943 (49,255) 13,569 110,145
Free Cash Flow (184,438) (122,962) (110,152) (77,752) (45,776)
Invested Capital 277,676 432,608 204,779 127,144 149,546
Shares Outstanding - Common Class Only 167,798 122,280 82,904 50,883 37,771
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 167,798 122,280 82,904 50,883 37,771
Total Common Shares Outstanding 167,798 122,280 82,904 50,883 37,771
Treasury Shares 7,568 7,568 7,568 7,568 -
Basic Weighted Shares Outstanding 132,732 106,150 69,742 50,360 36,909
Diluted Weighted Shares Outstanding 140,514 106,150 70,381 50,360 36,909